Coronary artery bypass grafting alone for advanced ischemic left ventricular dysfunction with significant mitral regurgitation: Early and midterm outcomes in a small series

dc.contributor.authorOgus N.T.
dc.contributor.authorUs M.H.
dc.contributor.authorOgus H.
dc.contributor.authorIsik O.
dc.date.accessioned2024-07-12T21:53:27Z
dc.date.available2024-07-12T21:53:27Z
dc.date.issued2004en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractIn 31 consecutive patients with ischemic left ventricular dysfunction and mitral regurgitation ranging from 2/4 to 3/4 (mean, 2.87 ± 0.34), we performed coronary bypass grafting alone and assessed early and midterm outcomes. Our patients' mean preoperative New York Heart Association functional class was 3.64 ± 0.48, and their mean left ventricular ejection fraction was 0.25 ± 0.05. Preoperative thallium imaging revealed that all patients had at minimum a partially reversible defect in the anterior wall. All patients survived the operation. Hospital length of stay ranged from 5 to 21 days (mean, 8.35 ± 4.07 days), and mean length of follow-up was 21.35 ± 13.24 months. Postoperatively, patients' functional classification improved to a mean of 1.32 ± 0.6; left ventricular ejection fraction improved to a mean of 0.43 ± 0.09; and severity of mitral regurgitation decreased to a mean of 1.35 ± 0.96. Statistical analysis showed that all improvements were significant. Five late cardiac deaths occurred. Preoperative variables showed no correlation with late death. However, postoperative left ventricular ejection fraction and mitral regurgitation did correlate with late death, which suggests that the reversibility of damaged ischemic myocardium plays an important role after revascularization. This study supports the concept that ischemic mitral regurgitation might well improve after myocardial revascularization regardless of its severity; therefore, it should not be corrected at the primary operation, except in patients with organic valvular changes.en_US
dc.identifier.endpage148en_US
dc.identifier.issn0730-2347
dc.identifier.issue2en_US
dc.identifier.pmid15212124en_US
dc.identifier.scopus2-s2.0-2942526845en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage143en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8504
dc.identifier.volume31en_US
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.relation.ispartofTexas Heart Institute Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY03494
dc.subjectArterial occlusive diseases/complicationsen_US
dc.subjectCardiomyopathy, congestive/surgeryen_US
dc.subjectCoronary artery bypassen_US
dc.subjectHeart failure, congestiveen_US
dc.subjectIschemiaen_US
dc.subjectLeft ventricular dysfunctionen_US
dc.subjectMitral regurgitationen_US
dc.subjectMitral valve insufficiencyen_US
dc.subjectMyocardial revascularizationen_US
dc.titleCoronary artery bypass grafting alone for advanced ischemic left ventricular dysfunction with significant mitral regurgitation: Early and midterm outcomes in a small seriesen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar